Cargando…

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma

INTRODUCTION: The prognostic value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in hepatocellular carcinoma (HCC) was established in previous reports. However, there is no evidence suggesting the prognostic value of transcriptomes associated with tumor FDG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyunjong, Choi, Joon Young, Joung, Je-Gun, Joh, Jae-Won, Kim, Jong Man, Hyun, Seung Hyup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841806/ https://www.ncbi.nlm.nih.gov/pubmed/35174098 http://dx.doi.org/10.3389/fonc.2022.845900

Ejemplares similares

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
por: So, Heejune, et al.
Publicado: (2023)

Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
por: Lee, Hyunjong, et al.
Publicado: (2022)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT
por: Nguyen, Xuan Canh, et al.
Publicado: (2015)

Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
por: Reinholdt, Kasper Basse, et al.
Publicado: (2022)

Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis
por: Lee, Hyunjong, et al.
Publicado: (2023)

Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET
por: McGeorge, Stephen, et al.
Publicado: (2021)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT
por: Chi, Alexander, et al.
Publicado: (2014)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery
por: Lee, Hyunjong, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

A Retrospective Study of predicting risk of Metastasis among FDG-avid Bone Lesions in (18)F-FDG PET/CT
por: Yao, Guangyu, et al.
Publicado: (2020)

FDG avid pulmonary amyloid nodule in a patient with metastatic renal cell cancer on 18F-FDG PET/CT
por: Lee, Marco Enoch, et al.
Publicado: (2021)

The expression of Ki-67 and Glypican -3 in hepatocellular carcinoma was evaluated by comparing DWI and (18)F-FDG PET/CT
por: Wang, Xuedong, et al.
Publicado: (2023)

Transient (18)FDG-avid hilar lymph node on PET/CT imaging in asymptomatic COVID-19
por: Karimi-Galougahi, Mahboobeh, et al.
Publicado: (2020)

Adrenal schwannoma can be FDG-Avid on PET/CT: case report and review of historic institutional pathology
por: Fackelmayer, Oliver J., et al.
Publicado: (2023)

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019)

FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011)

Active Shingles Infection as Detected on (18)F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2013)

The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations
por: Liu, Yiyan
Publicado: (2016)

Pediatric Nasopharyngeal Carcinoma as Seen on 18F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2019)

Impact of Renal Failure on F18-FDG PET/CT Scans
por: Kode, Vishwajit, et al.
Publicado: (2017)

A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer
por: Lee, Hyunjong, et al.
Publicado: (2023)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

Investigating (18)F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review
por: Wang, Hongxi, et al.
Publicado: (2021)

Prognostic prediction by (18)F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis
por: Hu, Ruimin, et al.
Publicado: (2023)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Intra-operative use of PET probe for localization of FDG avid lesions
por: Molina, M.A., et al.
Publicado: (2009)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
por: Lee, Hyunjong, et al.
Publicado: (2022)

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors
por: Annovazzi, Alessio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8c1k04u36a390rsubpcc7hh6ue